Related Experiment Video
Updated: Nov 19, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
[COVID-19 and renal transplantation].
Florina Regele1, Rainer Oberbauer1
1Univ. Klinik für Innere Medizin III, Klinische Abteilung für Nephrologie und Dialyse, Medizinische Universität Wien, Währinger Gürtel 18-20, 1090 Wien, Österreich.
Kidney transplant recipients face high COVID-19 risks due to comorbidities and immunosuppression. Management involves careful adjustment of immunosuppressive drugs and exploring treatments like dexamethasone.
Area of Science:
- Nephrology
- Infectious Diseases
- Immunology
Context:
- The COVID-19 pandemic presents significant risks for kidney transplant recipients.
- These patients often have comorbidities and are on immunosuppressive therapy, complicating their response to infection.
- Published data indicates high hospitalization and mortality rates (13-23%) in this vulnerable group.
Purpose:
- To review the risks and management strategies for kidney transplant recipients with COVID-19.
- To discuss the complex role of immunosuppression in COVID-19 outcomes for these patients.
- To highlight current treatment approaches and ongoing research for SARS-CoV-2 in kidney transplant recipients.
Summary:
- COVID-19 poses a severe threat to kidney transplant recipients due to comorbidities and immunosuppression.
- Clinical presentation and risk factors for severe disease appear similar to the general population.
- Management requires careful adjustment of immunosuppressive therapy based on disease severity.
- Dexamethasone is currently the only proven effective treatment for those needing oxygen, with ongoing trials for other therapies.
Impact:
- Informs clinical decision-making for managing COVID-19 in kidney transplant patients.
- Highlights the need for tailored immunosuppression strategies.
- Emphasizes the importance of ongoing research into effective treatments for this high-risk population.
- Contributes to understanding the specific challenges faced by immunocompromised individuals during viral pandemics.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Continuous Renal Replacement Therapy

